Global Liquid Biopsy Market Growth (Status and Outlook) 2026-2032

October 2026 | 122 pages | ID: G20C64D9880FEN
LP Information

Abstracts

The global Liquid Biopsy market size is predicted to grow from US$ 4487 million in 2025 to US$ 16020 million in 2032; it is expected to grow at a CAGR of 19.9% from 2026 to 2032.

Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.

The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.

Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.

Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.

The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.

LPI (LP Information)' newest research report, the “Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Liquid Biopsy sales in 2025, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy sales for 2026 through 2032. With Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy.

This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• ctDNA Test
• CTC Test
• Exosome Test
• Cell-free RNA Test
• Other

Segmentation by Technology Platform:

• NGS Sequencing
• Digital PCR
• Real-time PCR
• Other

Segmentation by Sample:

• Blood Sample
• Urine Sample
• Other

Segmentation by Application:

• Hospitals Labs
• Reference Labs
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Guardant Health
• Grail
• Natera
• Roche
• Roche Diagnostics
• Qiagen
• Bio-Rad
• Thermo Fisher Scientific
• Exact Sciences
• Illumina
• Burning Rock Biotech
• Novogen
• Berry Oncology
• BGI
• MDxHealth
• NeoGenomics Laboraories
• Myriad Genetics
• Aide Bio

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Liquid Biopsy Market Size (2021-2032)
  2.1.2 Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Liquid Biopsy by Country/Region (2021, 2025 & 2032)
2.2 Liquid Biopsy Segment by Type
  2.2.1 ctDNA Test
  2.2.2 CTC Test
  2.2.3 Exosome Test
  2.2.4 Cell-free RNA Test
  2.2.5 Other
  2.2.6 Liquid Biopsy Market Size by Type
    2.2.6.1 Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
2.3 Liquid Biopsy Segment by Technology Platform
  2.3.1 NGS Sequencing
  2.3.2 Digital PCR
  2.3.3 Real-time PCR
  2.3.4 Other
  2.3.5 Liquid Biopsy Market Size by Technology Platform
    2.3.5.1 Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032)
    2.3.5.2 Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
2.4 Liquid Biopsy Segment by Sample
  2.4.1 Blood Sample
  2.4.2 Urine Sample
  2.4.3 Other
  2.4.4 Liquid Biopsy Market Size by Sample
    2.4.4.1 Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032)
    2.4.4.2 Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
2.5 Liquid Biopsy Segment by Application
  2.5.1 Hospitals Labs
  2.5.2 Reference Labs
  2.5.3 Other
  2.5.4 Liquid Biopsy Market Size by Application
    2.5.4.1 Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global Liquid Biopsy Market Size Market Share by Application (2021-2026)

3 LIQUID BIOPSY MARKET SIZE BY PLAYER

3.1 Liquid Biopsy Market Size Market Share by Player
  3.1.1 Global Liquid Biopsy Revenue by Player (2021-2026)
  3.1.2 Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
3.2 Global Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LIQUID BIOPSY BY REGION

4.1 Liquid Biopsy Market Size by Region (2021-2026)
4.2 Global Liquid Biopsy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Liquid Biopsy Market Size Growth (2021-2026)
4.4 APAC Liquid Biopsy Market Size Growth (2021-2026)
4.5 Europe Liquid Biopsy Market Size Growth (2021-2026)
4.6 Middle East & Africa Liquid Biopsy Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Liquid Biopsy Market Size by Country (2021-2026)
5.2 Americas Liquid Biopsy Market Size by Type (2021-2026)
5.3 Americas Liquid Biopsy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Liquid Biopsy Market Size by Region (2021-2026)
6.2 APAC Liquid Biopsy Market Size by Type (2021-2026)
6.3 APAC Liquid Biopsy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Liquid Biopsy Market Size by Country (2021-2026)
7.2 Europe Liquid Biopsy Market Size by Type (2021-2026)
7.3 Europe Liquid Biopsy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Liquid Biopsy by Region (2021-2026)
8.2 Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026)
8.3 Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LIQUID BIOPSY MARKET FORECAST

10.1 Global Liquid Biopsy Forecast by Region (2027-2032)
  10.1.1 Global Liquid Biopsy Forecast by Region (2027-2032)
  10.1.2 Americas Liquid Biopsy Forecast
  10.1.3 APAC Liquid Biopsy Forecast
  10.1.4 Europe Liquid Biopsy Forecast
  10.1.5 Middle East & Africa Liquid Biopsy Forecast
10.2 Americas Liquid Biopsy Forecast by Country (2027-2032)
  10.2.1 United States Market Liquid Biopsy Forecast
  10.2.2 Canada Market Liquid Biopsy Forecast
  10.2.3 Mexico Market Liquid Biopsy Forecast
  10.2.4 Brazil Market Liquid Biopsy Forecast
10.3 APAC Liquid Biopsy Forecast by Region (2027-2032)
  10.3.1 China Liquid Biopsy Market Forecast
  10.3.2 Japan Market Liquid Biopsy Forecast
  10.3.3 Korea Market Liquid Biopsy Forecast
  10.3.4 Southeast Asia Market Liquid Biopsy Forecast
  10.3.5 India Market Liquid Biopsy Forecast
  10.3.6 Australia Market Liquid Biopsy Forecast
10.4 Europe Liquid Biopsy Forecast by Country (2027-2032)
  10.4.1 Germany Market Liquid Biopsy Forecast
  10.4.2 France Market Liquid Biopsy Forecast
  10.4.3 UK Market Liquid Biopsy Forecast
  10.4.4 Italy Market Liquid Biopsy Forecast
  10.4.5 Russia Market Liquid Biopsy Forecast
10.5 Middle East & Africa Liquid Biopsy Forecast by Region (2027-2032)
  10.5.1 Egypt Market Liquid Biopsy Forecast
  10.5.2 South Africa Market Liquid Biopsy Forecast
  10.5.3 Israel Market Liquid Biopsy Forecast
  10.5.4 Turkey Market Liquid Biopsy Forecast
10.6 Global Liquid Biopsy Forecast by Type (2027-2032)
10.7 Global Liquid Biopsy Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Liquid Biopsy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Guardant Health
  11.1.1 Guardant Health Company Information
  11.1.2 Guardant Health Liquid Biopsy Product Offered
  11.1.3 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Guardant Health Main Business Overview
  11.1.5 Guardant Health Latest Developments
11.2 Grail
  11.2.1 Grail Company Information
  11.2.2 Grail Liquid Biopsy Product Offered
  11.2.3 Grail Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Grail Main Business Overview
  11.2.5 Grail Latest Developments
11.3 Natera
  11.3.1 Natera Company Information
  11.3.2 Natera Liquid Biopsy Product Offered
  11.3.3 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Natera Main Business Overview
  11.3.5 Natera Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Liquid Biopsy Product Offered
  11.4.3 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Roche Diagnostics
  11.5.1 Roche Diagnostics Company Information
  11.5.2 Roche Diagnostics Liquid Biopsy Product Offered
  11.5.3 Roche Diagnostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Roche Diagnostics Main Business Overview
  11.5.5 Roche Diagnostics Latest Developments
11.6 Qiagen
  11.6.1 Qiagen Company Information
  11.6.2 Qiagen Liquid Biopsy Product Offered
  11.6.3 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Qiagen Main Business Overview
  11.6.5 Qiagen Latest Developments
11.7 Bio-Rad
  11.7.1 Bio-Rad Company Information
  11.7.2 Bio-Rad Liquid Biopsy Product Offered
  11.7.3 Bio-Rad Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Bio-Rad Main Business Overview
  11.7.5 Bio-Rad Latest Developments
11.8 Thermo Fisher Scientific
  11.8.1 Thermo Fisher Scientific Company Information
  11.8.2 Thermo Fisher Scientific Liquid Biopsy Product Offered
  11.8.3 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Thermo Fisher Scientific Main Business Overview
  11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Exact Sciences
  11.9.1 Exact Sciences Company Information
  11.9.2 Exact Sciences Liquid Biopsy Product Offered
  11.9.3 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Exact Sciences Main Business Overview
  11.9.5 Exact Sciences Latest Developments
11.10 Illumina
  11.10.1 Illumina Company Information
  11.10.2 Illumina Liquid Biopsy Product Offered
  11.10.3 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Illumina Main Business Overview
  11.10.5 Illumina Latest Developments
11.11 Burning Rock Biotech
  11.11.1 Burning Rock Biotech Company Information
  11.11.2 Burning Rock Biotech Liquid Biopsy Product Offered
  11.11.3 Burning Rock Biotech Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Burning Rock Biotech Main Business Overview
  11.11.5 Burning Rock Biotech Latest Developments
11.12 Novogen
  11.12.1 Novogen Company Information
  11.12.2 Novogen Liquid Biopsy Product Offered
  11.12.3 Novogen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Novogen Main Business Overview
  11.12.5 Novogen Latest Developments
11.13 Berry Oncology
  11.13.1 Berry Oncology Company Information
  11.13.2 Berry Oncology Liquid Biopsy Product Offered
  11.13.3 Berry Oncology Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Berry Oncology Main Business Overview
  11.13.5 Berry Oncology Latest Developments
11.14 BGI
  11.14.1 BGI Company Information
  11.14.2 BGI Liquid Biopsy Product Offered
  11.14.3 BGI Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 BGI Main Business Overview
  11.14.5 BGI Latest Developments
11.15 MDxHealth
  11.15.1 MDxHealth Company Information
  11.15.2 MDxHealth Liquid Biopsy Product Offered
  11.15.3 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 MDxHealth Main Business Overview
  11.15.5 MDxHealth Latest Developments
11.16 NeoGenomics Laboraories
  11.16.1 NeoGenomics Laboraories Company Information
  11.16.2 NeoGenomics Laboraories Liquid Biopsy Product Offered
  11.16.3 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 NeoGenomics Laboraories Main Business Overview
  11.16.5 NeoGenomics Laboraories Latest Developments
11.17 Myriad Genetics
  11.17.1 Myriad Genetics Company Information
  11.17.2 Myriad Genetics Liquid Biopsy Product Offered
  11.17.3 Myriad Genetics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Myriad Genetics Main Business Overview
  11.17.5 Myriad Genetics Latest Developments
11.18 Aide Bio
  11.18.1 Aide Bio Company Information
  11.18.2 Aide Bio Liquid Biopsy Product Offered
  11.18.3 Aide Bio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Aide Bio Main Business Overview
  11.18.5 Aide Bio Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Liquid Biopsy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of ctDNA Test
Table 4. Major Players of CTC Test
Table 5. Major Players of Exosome Test
Table 6. Major Players of Cell-free RNA Test
Table 7. Major Players of Other
Table 8. Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 11. Major Players of NGS Sequencing
Table 12. Major Players of Digital PCR
Table 13. Major Players of Real-time PCR
Table 14. Major Players of Other
Table 15. Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Liquid Biopsy Market Size by Technology Platform (2021-2026) & ($ millions)
Table 17. Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
Table 18. Major Players of Blood Sample
Table 19. Major Players of Urine Sample
Table 20. Major Players of Other
Table 21. Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Liquid Biopsy Market Size by Sample (2021-2026) & ($ millions)
Table 23. Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
Table 24. Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 27. Global Liquid Biopsy Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
Table 29. Liquid Biopsy Key Players Head office and Products Offered
Table 30. Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 35. Global Liquid Biopsy Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Liquid Biopsy Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 39. Americas Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 41. Americas Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 43. APAC Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 45. APAC Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 49. Europe Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Liquid Biopsy
Table 55. Key Market Challenges & Risks of Liquid Biopsy
Table 56. Key Industry Trends of Liquid Biopsy
Table 57. Global Liquid Biopsy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Liquid Biopsy Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Liquid Biopsy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Liquid Biopsy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Guardant Health Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 62. Guardant Health Liquid Biopsy Product Offered
Table 63. Guardant Health Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Guardant Health Main Business
Table 65. Guardant Health Latest Developments
Table 66. Grail Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 67. Grail Liquid Biopsy Product Offered
Table 68. Grail Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Grail Main Business
Table 70. Grail Latest Developments
Table 71. Natera Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 72. Natera Liquid Biopsy Product Offered
Table 73. Natera Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Natera Main Business
Table 75. Natera Latest Developments
Table 76. Roche Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 77. Roche Liquid Biopsy Product Offered
Table 78. Roche Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Roche Diagnostics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 82. Roche Diagnostics Liquid Biopsy Product Offered
Table 83. Roche Diagnostics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Roche Diagnostics Main Business
Table 85. Roche Diagnostics Latest Developments
Table 86. Qiagen Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 87. Qiagen Liquid Biopsy Product Offered
Table 88. Qiagen Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Qiagen Main Business
Table 90. Qiagen Latest Developments
Table 91. Bio-Rad Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 92. Bio-Rad Liquid Biopsy Product Offered
Table 93. Bio-Rad Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Bio-Rad Main Business
Table 95. Bio-Rad Latest Developments
Table 96. Thermo Fisher Scientific Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 97. Thermo Fisher Scientific Liquid Biopsy Product Offered
Table 98. Thermo Fisher Scientific Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Thermo Fisher Scientific Main Business
Table 100. Thermo Fisher Scientific Latest Developments
Table 101. Exact Sciences Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 102. Exact Sciences Liquid Biopsy Product Offered
Table 103. Exact Sciences Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Exact Sciences Main Business
Table 105. Exact Sciences Latest Developments
Table 106. Illumina Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 107. Illumina Liquid Biopsy Product Offered
Table 108. Illumina Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Illumina Main Business
Table 110. Illumina Latest Developments
Table 111. Burning Rock Biotech Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 112. Burning Rock Biotech Liquid Biopsy Product Offered
Table 113. Burning Rock Biotech Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Burning Rock Biotech Main Business
Table 115. Burning Rock Biotech Latest Developments
Table 116. Novogen Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 117. Novogen Liquid Biopsy Product Offered
Table 118. Novogen Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Novogen Main Business
Table 120. Novogen Latest Developments
Table 121. Berry Oncology Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 122. Berry Oncology Liquid Biopsy Product Offered
Table 123. Berry Oncology Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Berry Oncology Main Business
Table 125. Berry Oncology Latest Developments
Table 126. BGI Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 127. BGI Liquid Biopsy Product Offered
Table 128. BGI Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BGI Main Business
Table 130. BGI Latest Developments
Table 131. MDxHealth Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 132. MDxHealth Liquid Biopsy Product Offered
Table 133. MDxHealth Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. MDxHealth Main Business
Table 135. MDxHealth Latest Developments
Table 136. NeoGenomics Laboraories Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 137. NeoGenomics Laboraories Liquid Biopsy Product Offered
Table 138. NeoGenomics Laboraories Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. NeoGenomics Laboraories Main Business
Table 140. NeoGenomics Laboraories Latest Developments
Table 141. Myriad Genetics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 142. Myriad Genetics Liquid Biopsy Product Offered
Table 143. Myriad Genetics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Myriad Genetics Main Business
Table 145. Myriad Genetics Latest Developments
Table 146. Aide Bio Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 147. Aide Bio Liquid Biopsy Product Offered
Table 148. Aide Bio Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Aide Bio Main Business
Table 150. Aide Bio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liquid Biopsy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Liquid Biopsy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Liquid Biopsy Sales Market Share by Country/Region (2025)
Figure 8. Liquid Biopsy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Liquid Biopsy Market Size Market Share by Type in 2025
Figure 10. Global Liquid Biopsy Market Size Market Share by Technology Platform in 2025
Figure 11. Global Liquid Biopsy Market Size Market Share by Sample in 2025
Figure 12. Liquid Biopsy in Hospitals Labs
Figure 13. Global Liquid Biopsy Market: Hospitals Labs (2021-2026) & ($ millions)
Figure 14. Liquid Biopsy in Reference Labs
Figure 15. Global Liquid Biopsy Market: Reference Labs (2021-2026) & ($ millions)
Figure 16. Liquid Biopsy in Other
Figure 17. Global Liquid Biopsy Market: Other (2021-2026) & ($ millions)
Figure 18. Global Liquid Biopsy Market Size Market Share by Application in 2025
Figure 19. Global Liquid Biopsy Revenue Market Share by Player in 2025
Figure 20. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 22. APAC Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 23. Europe Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 25. Americas Liquid Biopsy Value Market Share by Country in 2025
Figure 26. United States Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Liquid Biopsy Market Size Market Share by Region in 2025
Figure 31. APAC Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 33. China Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Liquid Biopsy Market Size Market Share by Country in 2025
Figure 40. Europe Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 56. APAC Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 57. Europe Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 59. United States Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 60. Canada Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 63. China Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 64. Japan Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 65. Korea Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 67. India Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 68. Australia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 69. Germany Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 70. France Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 71. UK Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 72. Italy Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 73. Russia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 76. Israel Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 78. Global Liquid Biopsy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Liquid Biopsy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Liquid Biopsy Market Size 2027-2032 ($ millions)